A former CDC supervisor admitted to embezzling over $190,000 in taxpayer money, highlighting vulnerabilities in federal payment systems.
| PULSE POINTS |
❓ WHAT HAPPENED: A former Center for Disease Control and Prevention (CDC) supervisor has pleaded guilty to embezzling almost $200,000 in government funds. 📺 DETAIL: Between approximately August 2023 and February 2025, Gwendolyn Brandon, a 43-year-old former supervisor at the CDC, created 46 fake invoices ranging from $2,230 to $9,970. Brandon used her position to exploit the CDC’s payment systems and the employees working under her supervision, who unknowingly processed the fake invoices and sent money to an account that Brandon controlled. The fake invoices claimed to come from vendors and contractors seeking payment for previous goods and services. According to federal prosecutors, Brandon managed to embezzle $190,461.50 intended for public health research and operations. The fraud scheme occurred while Brandon was working at the CDC’s headquarters in Atlanta, Georgia. The investigation into Brandon’s fraud scheme was conducted by the Office of Inspector General at the United States Department of Health and Human Services. Marcus L. Sykes, special agent in charge of the Office of Inspector General, called Brandon a “federal employee-turned-fraudster.“ 🎯 IMPACT: Brandon’s sentencing is scheduled for September 3. She will be sentenced before U.S. District Judge Steven D. Grimberg in federal court. She is permanently banned from federal employment or contracting with the federal government and its agencies, as part of her plea agreement with the court. The case underscores vulnerabilities in federal payment systems and highlights the need for stricter internal controls to prevent waste, fraud, and abuse. 💬 KEY QUOTE: “This defendant embezzled taxpayer money and brazenly exploited her position of public trust by fabricating invoices… When she is sentenced later this year, she will pay the price for her greed and deception.” – U.S. Attorney Theodore S. Hertzberg. |
Join Pulse+ to comment below, and receive exclusive e-mail analyses.
show less